Imunon receives Nasdaq notice for failing to meet $2.5M stockholders' equity requirement

Imunon, Inc.

Nasdaq notified Imunon on May 19, 2025 of non-compliance with minimum stockholders' equity of $2.5M (Listing Rule 5550(b)(1)).
Company has until July 3, 2025 to submit a compliance plan; if accepted, Nasdaq may grant up to 180 days to regain compliance.
Failure to regain compliance could lead to delisting; company would have right to a hearing before Nasdaq Hearings Panel.
Deficiency is unrelated to prior notice regarding minimum bid price requirement disclosed in November 2024.
Company evaluating options to regain compliance but cautions no assurance of success.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.